Capital International Sarl’s Amgen AMGN Stock Holding History

Capital International Sarl’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.1M	Sell	74,744 -19,772	-21%	-$6.77M	0.38%	60
2026 Q1	$33.3M	Buy	94,516 +6,630	+8%	+$2.36M	0.54%	48
2025 Q4	$28.8M	Sell	87,886 -37,234	-30%	-$11.8M	0.46%	56
2025 Q3	$35.3M	Buy	125,120 +46,052	+58%	+$13.4M	0.61%	48
2025 Q2	$22.1M	Buy	79,068 +9,116	+13%	+$2.58M	0.42%	66
2025 Q1	$21.8M	Buy	69,952 +59,026	+540%	+$17.4M	0.49%	59
2024 Q4	$2.85M	Buy	10,926 +7,071	+183%	+$2.1M	0.07%	158
2024 Q3	$1.24M	Sell	3,855 -705	-15%	-$231K	0.03%	206
2024 Q2	$1.42M	Buy	+4,560	New	+$1.34M	0.04%	191
2022 Q1	–	Sell	-11,271	Closed	-$2.54M	–	259
2021 Q4	$2.54M	Buy	11,271 +1,554	+16%	+$328K	0.12%	170
2021 Q3	$2.07M	Buy	+9,717	New	+$2.24M	0.18%	137

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Capital International Sarl's AMGN Position: Q2 2026 in Review

Capital International Sarl reduced its Amgen (AMGN) stake by 21% in Q2 2026, selling an estimated $6.77M and leaving 74,744 shares worth $27.1M. The position accounts for 0.38% of the portfolio, ranked #60.

Capital International Sarl first reported a position in AMGN in Q3 2021 and has held it in 11 quarters since. The position peaked at $35.3M in Q3 2025. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Capital International Sarl held 74,744 shares of Amgen worth $27.1M as of Q2 2026.
Capital International Sarl sold 19,772 Amgen shares in Q2 2026, an estimated $6.77M.
Amgen made up 0.38% of Capital International Sarl's portfolio in Q2 2026, its #60 holding.
Capital International Sarl first reported a position in Amgen in Q3 2021 and has held it in 11 quarters since.
Capital International Sarl's Amgen position peaked at $35.3M in Q3 2025.
3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.